← Founder Radar · Category
Nutraceuticals D2c
90-day signals
1
Total funded
$7.2M
Launches
0
14-day momentum
ZeroHarm Sciences (India) raised $7.2M Series A led by Kotak Alternate Asset Managers to scale supplement D2C and expand overseas. Growth trajectory signals investor confidence in India-first wellness brands entering regulated export markets. Gap: regulatory compliance and supply chain traceability for supplements remain underserved.
Get the weekly deep dive in your inbox
Every Sunday, we go three levels deep on the strongest pattern of the week — competitive density, pricing benchmarks, and the underserved edge.
Thanks — you're on the list. See you Sunday.
No spam. Unsubscribe anytime. One email a week.